{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:03:44Z","timestamp":1776089024073,"version":"3.50.1"},"reference-count":65,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Recent advances in molecular genetics, particularly in identifying and characterizing genetic abnormalities within mesenchymal neoplasms, have led to a more comprehensive and evolving classification system. Modern technological developments in cytogenetics and next-generation sequencing have enabled the analysis of small clinical samples, expanded our understanding of tumor biology, and improved the diagnostic, prognostic, and predictive precision by identifying targeted genetic alterations, confirming the presence of fusion transcripts, and\/or revealing the overexpression of specific genes and their targets. In this review, we focus specifically on the GLI1-rearranged enteric tumor, a recent clinicopathological entity that has emerged within the expanding classification of mesenchymal tumors. Herein, we aim to explore the histopathological features, molecular genetic characteristics, and clinical outcomes in these tumors. Due to their rarity and the extensive overlapping in their histopathological and molecular features with other neoplasms, continued research and systematic documentation of GLI1-rearranged enteric tumors is necessary to better understand their biological behavior, develop more accurate prognostic indicators, and establish optimal treatment strategies.<\/jats:p>","DOI":"10.3390\/cells14020118","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T11:28:31Z","timestamp":1736854111000},"page":"118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GLI1-Rearranged Enteric Tumors: Updates on Clinicopathologic and Molecular Genetics Features"],"prefix":"10.3390","volume":"14","author":[{"given":"Ahmed I.","family":"Younes","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3695-8192","authenticated-orcid":false,"given":"Haider A.","family":"Mejbel","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/PAS.0000000000001950","article-title":"GLI1-Rearranged Enteric Tumor: Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene Fusions","volume":"47","author":"Jessurun","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/PAS.0000000000001360","article-title":"Pericytoma with t(7;12) and ACTB-GLI1 Fusion: Reevaluation of an Unusual Entity and its Relationship to the Spectrum of GLI1 Fusion-related Neoplasms","volume":"43","author":"Kerr","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100635","DOI":"10.1016\/j.modpat.2024.100635","article-title":"GLI1-Altered Mesenchymal Tumor-Multiomic Characterization of a Case Series and Patient-Level Meta-analysis of One Hundred Sixty-Seven Cases for Risk Stratification","volume":"38","author":"Yeung","year":"2024","journal-title":"Mod. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/PAS.0000000000002272","article-title":"A Comprehensive Clinicopathologic and Molecular Reappraisal of GLI1-altered Mesenchymal Tumors with Pooled Outcome Analysis Showing Poor Survival in GLI1-amplified Versus GLI1-rearranged Tumors","volume":"48","author":"Saoud","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/PAS.0000000000001010","article-title":"A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB\/MALAT1\/PTCH1-GLI1 Fusions","volume":"42","author":"Antonescu","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_6","first-page":"1389","article-title":"Expanding the Spectrum of GLI1-rearranged Neoplasms of the Gastrointestinal Tract to Include Monophasic Keratin-positive Epithelial Neoplasms","volume":"48","author":"Bahceci","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"100386","DOI":"10.1016\/j.modpat.2023.100386","article-title":"GLI1-Altered Mesenchymal Tumors With ACTB or PTCH1 Fusion: A Molecular and Clinicopathologic Analysis","volume":"37","author":"Kerr","year":"2024","journal-title":"Mod. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11604-022-01305-x","article-title":"Gastrointestinal stromal tumors: A comprehensive radiological review","volume":"40","author":"Inoue","year":"2022","journal-title":"Jpn. J. Radiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.5152\/tjg.2022.21847","article-title":"Accuracy of Endoscopic Ultrasonography for Determining the Depth of Invasion in Early Gastric Cancer","volume":"33","author":"Kim","year":"2022","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000001439","article-title":"Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis","volume":"44","author":"Xu","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e943271","DOI":"10.12659\/AJCR.943271","article-title":"Duodenal Soft Tissue Sarcoma with GLI1 Gene Rearrangement: A Case Report and Literature Review","volume":"25","author":"Li","year":"2024","journal-title":"Am. J. Case Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00428-023-03687-3","article-title":"The value of GLI1 and p16 immunohistochemistry in the premolecular screening for GLI1-altered mesenchymal neoplasms","volume":"484","author":"Machado","year":"2024","journal-title":"Virchows Arch."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/PAS.0000000000001751","article-title":"Pseudoendocrine Sarcoma: Clinicopathologic Analysis of 23 Cases of a Distinctive Soft Tissue Neoplasm with Metastatic Potential, Recurrent CTNNB1 Mutations, and a Predilection for Truncal Locations","volume":"46","author":"Papke","year":"2022","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12105-015-0618-0","article-title":"Myoepithelial neoplasms of soft tissue: An updated review of the clinicopathologic, immunophenotypic, and genetic features","volume":"9","author":"Jo","year":"2015","journal-title":"Head. Neck Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/gcc.22102","article-title":"Novel MIR143-NOTCH fusions in benign and malignant glomus tumors","volume":"52","author":"Mosquera","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.humpath.2016.02.015","article-title":"Translocation t(7;12) as the sole chromosomal abnormality resulting in ACTB-GLI1 fusion in pediatric gastric pericytoma","volume":"53","author":"Castro","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.humpath.2012.01.019","article-title":"Pericytoma with t(7;12) and ACTB-GLI1 fusion arising in bone","volume":"43","author":"Bridge","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1159\/000514145","article-title":"Primary Small Intestinal Sarcomatoid Carcinoma: Report of a Rare Case and Literature Review","volume":"14","author":"Karakuchi","year":"2021","journal-title":"Case Rep. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/01.pas.0000167056.13614.62","article-title":"Morphologic and immunophenotypic diversity in Ewing family tumors: A study of 66 genetically confirmed cases","volume":"29","author":"Folpe","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/10935266221088151","article-title":"Selective Immunoreactivity for WT1 Carboxy-Terminus Distinguishes Desmoplastic Small Round Cell Tumor From its Histologic Mimics","volume":"25","author":"Wong","year":"2022","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5858\/arpa.2020-0773-RA","article-title":"Small Round Cell Tumors of Soft Tissue and Bone","volume":"146","author":"Wei","year":"2022","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/s41467-023-37049-z","article-title":"ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma","volume":"14","author":"Tanaka","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Iyengar, B., and Singh, A.V. (2010). Patterns of neural differentiation in melanomas. J. Biomed. Sci., 17.","DOI":"10.1186\/1423-0127-17-87"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/PAS.0000000000002018","article-title":"GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics","volume":"47","author":"Parrack","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cancergen.2011.07.008","article-title":"Promiscuous partnerships in Ewing\u2019s sarcoma","volume":"204","author":"Sankar","year":"2011","journal-title":"Cancer Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00256-018-2908-6","article-title":"Clinical, radiological, and pathological features of extraskeletal osteosarcoma","volume":"47","author":"Roller","year":"2018","journal-title":"Skeletal Radiol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Avery, J.T., Zhang, R., and Boohaker, R.J. (2021). GLI1: A Therapeutic Target for Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.673154"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/path.4730","article-title":"Recurrent MALAT1-GLI1 oncogenic fusion and GLI1 up-regulation define a subset of plexiform fibromyxoma","volume":"239","author":"Spans","year":"2016","journal-title":"J. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0002-9440(10)63723-6","article-title":"Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: Pericytoma with t(7;12)","volume":"164","author":"Dahlen","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/PAS.0000000000000862","article-title":"Myopericytomatosis: Clinicopathologic Analysis of 11 Cases With Molecular Identification of Recurrent PDGFRB Alterations in Myopericytomatosis and Myopericytoma","volume":"41","author":"Hung","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nishio, J., Nakayama, S., Koga, K., and Aoki, M. (2024). Keratin-Positive Giant Cell-Rich Tumor: A Review and Update. Cancers, 16.","DOI":"10.3390\/cancers16101940"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wojtys, W., and Oron, M. (2023). How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors. Cancers, 15.","DOI":"10.3390\/cancers15112918"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Coucha, M., Shanab, A.Y., Sayed, M., Vazdarjanova, A., and El-Remessy, A.B. (2019). Modulating Expression of Thioredoxin Interacting Protein (TXNIP) Prevents Secondary Damage and Preserves Visual Function in a Mouse Model of Ischemia\/Reperfusion. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163969"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Wang, C.Y., Chang, Y.C., Kuo, Y.L., Lee, K.T., Chen, P.S., Cheung, C.H.A., Chang, C.P., Phan, N.N., Shen, M.R., and Hsu, H.P. (2019). Mutation of the PTCH1 gene predicts recurrence of breast cancer. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-52617-4"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.6004\/jnccn.2021.7058","article-title":"PTCH1-GLI1 Fusion-Positive Ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib","volume":"19","author":"Alwaqfi","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Di Cintio, F., Dal Bo, M., Baboci, L., De Mattia, E., Polano, M., and Toffoli, G. (2020). The Molecular and Microenvironmental Landscape of Glioblastomas: Implications for the Novel Treatment Choices. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.603647"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jcmgh.2014.12.008","article-title":"Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology","volume":"1","author":"Kidd","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41392-022-01168-8","article-title":"Protein tyrosine kinase inhibitor resistance in malignant tumors: Molecular mechanisms and future perspective","volume":"7","author":"Yang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_39","first-page":"17","article-title":"Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR-34a\/cyclin D1 axis","volume":"54","author":"Duan","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/1878-0261.12366","article-title":"Identification of novel GLI1 target genes and regulatory circuits in human cancer cells","volume":"12","author":"Diao","year":"2018","journal-title":"Mol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1038\/sj.onc.1210241","article-title":"Gli1 acts through Snail and E-cadherin to promote nuclear signaling by beta-catenin","volume":"26","author":"Li","year":"2007","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"10342","DOI":"10.1093\/nar\/gkz1175","article-title":"Hedgehog signaling enables repair of ribosomal DNA double-strand breaks","volume":"48","author":"Lin","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Jeng, K.S., Chang, C.F., and Lin, S.S. (2020). Sonic Hedgehog Signaling in Organogenesis, Tumors, and Tumor Microenvironments. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030758"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sari, I.N., Phi, L.T.H., Jun, N., Wijaya, Y.T., Lee, S., and Kwon, H.Y. (2018). Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells. Cells, 7.","DOI":"10.3390\/cells7110208"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"dev195552","DOI":"10.1242\/dev.195552","article-title":"Hedgehog signaling and the primary cilium: Implications for spatial and temporal constraints on signaling","volume":"148","author":"Ho","year":"2021","journal-title":"Development"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1126\/science.1139740","article-title":"Patched1 regulates hedgehog signaling at the primary cilium","volume":"317","author":"Rohatgi","year":"2007","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0091-679X(08)94010-3","article-title":"The primary cilium as a Hedgehog signal transduction machine","volume":"94","author":"Goetz","year":"2009","journal-title":"Methods Cell Biol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Sigafoos, A.N., Paradise, B.D., and Fernandez-Zapico, M.E. (2021). Hedgehog\/GLI Signaling Pathway: Transduction, Regulation, and Implications for Disease. Cancers, 13.","DOI":"10.3390\/cancers13143410"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-394622-5.00003-1","article-title":"Noncanonical Hedgehog signaling","volume":"88","author":"Brennan","year":"2012","journal-title":"Vitam. Horm."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Doheny, D., Manore, S.G., Wong, G.L., and Lo, H.W. (2020). Hedgehog Signaling and Truncated GLI1 in Cancer. Cells, 9.","DOI":"10.3390\/cells9092114"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Iriana, S., Asha, K., Repak, M., and Sharma-Walia, N. (2021). Hedgehog Signaling: Implications in Cancers and Viral Infections. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031042"},{"key":"ref_52","first-page":"105","article-title":"Hedgehog pathway and GLI1 isoforms in human cancer","volume":"13","author":"Carpenter","year":"2012","journal-title":"Discov. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e36516","DOI":"10.1016\/j.heliyon.2024.e36516","article-title":"Hedgehog\/Gli2 signaling triggers cell proliferation and metastasis via EMT and wnt\/beta-catenin pathways in oral squamous cell carcinoma","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12964-020-00540-x","article-title":"GLI3: A mediator of genetic diseases, development and cancer","volume":"18","author":"Matissek","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive Review of Uterine Fibroids: Developmental Origin, Pathogenesis, and Treatment","volume":"43","author":"Yang","year":"2022","journal-title":"Endocr. Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1007\/s12105-022-01476-z","article-title":"GLI1-Altered Soft Tissue Tumors of the Head and Neck: Frequent Oropharyngeal Involvement, p16 Immunoreactivity, and Detectable Alterations by DDIT3 Break Apart FISH","volume":"16","author":"Palsgrove","year":"2022","journal-title":"Head. Neck Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/1066896919900548","article-title":"A Malignant Neoplasm From the Jejunum With a MALAT1-GLI1 Fusion and 26-Year Survival History","volume":"28","author":"Prall","year":"2020","journal-title":"Int. J. Surg. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"69087","DOI":"10.18632\/oncotarget.12011","article-title":"Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1158\/0008-5472.CAN-17-2897","article-title":"A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors","volume":"78","author":"Rahman","year":"2018","journal-title":"Cancer Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ccell.2015.02.001","article-title":"Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma","volume":"27","author":"Sharpe","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zhang, R., Ma, J., Avery, J.T., Sambandam, V., Nguyen, T.H., Xu, B., Suto, M.J., and Boohaker, R.J. (2020). GLI1 Inhibitor SRI-38832 Attenuates Chemotherapeutic Resistance by Downregulating NBS1 Transcription in BRAF(V600E) Colorectal Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00241"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Chai, J.Y., Sugumar, V., Alshanon, A.F., Wong, W.F., Fung, S.Y., and Looi, C.Y. (2021). Defining the Role of GLI\/Hedgehog Signaling in Chemoresistance: Implications in Therapeutic Approaches. Cancers, 13.","DOI":"10.3390\/cancers13194746"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"105252","DOI":"10.1016\/j.oraloncology.2021.105252","article-title":"Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis","volume":"119","author":"Fiacchini","year":"2021","journal-title":"Oral. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/s41388-021-01783-9","article-title":"Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma","volume":"40","author":"Pietrobono","year":"2021","journal-title":"Oncogene"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1038\/s41388-024-03105-1","article-title":"GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway","volume":"43","author":"Ikeuchi","year":"2024","journal-title":"Oncogene"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/2\/118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:28:50Z","timestamp":1759919330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/2\/118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["cells14020118"],"URL":"https:\/\/doi.org\/10.3390\/cells14020118","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]}}}